Nanjing Vazyme Biotech Co., Ltd. (688105.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 21.79

From 52W high−11.79%

Volume15.58M

Market capCNY 11.64B

P/E (TTM)−700.5x

P/S (TTM)8.0x

Div yield2.98%

Key dataSep 18, 2026

Open

CNY 21.79

From 52W high

−11.79%

Volume

15.58M

Market cap

CNY 11.64B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

93.0x

P/E (TTM)

−700.5x

RSI (14)

55.8

MomentumView details →

1D Return

−7.14%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−700.5x

EV/EBITDA

93.0x

EV/Sales

8.0x

P/S (TTM)

8.0x

P/B (TTM)

3.2x

ProfitabilityView details →

Gross Margin

69.91%

Net Margin

−1.01%

EBITDA Margin

8.62%

ROE (TTM)

−0.38%

ROA (TTM)

−0.28%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

+3.84%

EPS YoY

+49.68%

FCF YoY

+500.74%

Revenue CAGR 3Y

−27.18%

EPS CAGR 3Y

+20.00%

EBITDA YoY

—

MomentumView details →

1D Return

−7.14%

YTD Return

—

1Y Return

—

RSI (14)

55.8

vs 50D SMA

+7.35%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

3.39x

Quick Ratio

3.08x

Div Yield

2.98%

Div Rate

CNY 0.65

Div Growth 1Y

+15.39%

EarningsView details →

EPS (Actual)

CNY 0.04

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.41B

Net Income (TTM)

−14.34M

Op. CF (TTM)

209.68M

Next earningsOct 26, 2026 →

Latest newsMore news →

No recent news for 688105.SH.

Similar companies

Mabwell-b02493.HK Corcept Therapeutics IncorporatedCORT Bio-Techne CorporationTECH 欧林生物688319.SH HBM Holdings Limited02142.HK Nanjing Leads Biolabs Co Ltd09887.HK Find similar companies →

Latest newsMore news →

No recent news for 688105.SH.